Affiliations
AffiliationsItem in Clipboard
The risk of cardiovascular disease following breast cancer by Framingham risk scoreSofie A M Gernaat et al. Breast Cancer Res Treat. 2018 Jul.
. 2018 Jul;170(1):119-127. doi: 10.1007/s10549-018-4723-0. Epub 2018 Feb 28. AffiliationsItem in Clipboard
AbstractObjectives: This study evaluates the risk of cardiovascular disease (CVD) following breast cancer, accounting for baseline CVD risk.
Methods: Within the EPIC-NL (Dutch part of the European Prospective Investigation into Nutrition and Cancer) cohort, 1103 women were diagnosed with breast cancer. For every breast cancer patient, 3-4 women without breast cancer (n = 4328) were selected matched for age, year, and time since cohort enrollment. Based on CVD risk factors at cohort enrollment, 10-year risk of CVD was calculated and categorized: low (< 10%), intermediate (10-20%), high (> 20%). Cox proportional hazard models assessed the risk of CVD events (hospitalization or mortality) and CVD mortality of women with versus without breast cancer, adjusted for baseline CVD risk.
Results: After median follow-up of 5 and 6 years, 92 (8.3%) and 325 (7.5%) CVD events occurred in women with and without breast cancer, respectively. In the low CVD risk group, women with breast cancer had 1.44 (95% CI 1.00-2.06) times higher risk of CVD events than women without breast cancer. In the intermediate and high CVD risk categories, risk of CVD events was similar in women with and without breast cancer. Overall, women with breast cancer had 1.77 (95% CI 1.10-2.86) times higher risk of CVD mortality than women without breast cancer.
Conclusions: Among women with low CVD risk, women with breast cancer have a higher risk of CVD event than women without breast cancer. Overall, women with breast cancer have a higher risk of CVD mortality than women without breast cancer.
Keywords: Breast cancer; Cardiovascular disease; Morbidity; Mortality; Risk.
Conflict of interest statement Conflict of interestThe authors declare that they have no conflict of interest.
Ethics approval and consent to participateThe study complies with the Declaration of Helsinki and was approved by the institutional board of the University Medical Center Utrecht (Prospect) and the Medical Ethical Committee of TNO Nutrition and Food Research (MORGEN).
Similar articlesBuddeke J, Gernaat SAM, Bots ML, van den Bongard DHJG, Grobbee DE, Vaartjes I, Verkooijen HM. Buddeke J, et al. BMJ Open. 2019 May 30;9(5):e022664. doi: 10.1136/bmjopen-2018-022664. BMJ Open. 2019. PMID: 31152022 Free PMC article.
Feng X, Deng Z, McCullough MS, May BJ, Selznick E, Sheng JY, Connor AE, Armstrong DK, Visvanathan K. Feng X, et al. Breast Cancer Res Treat. 2025 Apr;210(3):737-748. doi: 10.1007/s10549-025-07611-y. Epub 2025 Feb 10. Breast Cancer Res Treat. 2025. PMID: 39928264
Haque R, Shi J, Schottinger JE, Chung J, Avila C, Amundsen B, Xu X, Barac A, Chlebowski RT. Haque R, et al. JAMA Oncol. 2016 Dec 1;2(12):1590-1597. doi: 10.1001/jamaoncol.2016.0429. JAMA Oncol. 2016. PMID: 27100398
Park NJ, Chang Y, Bender C, Conley Y, Chlebowski RT, van Londen GJ, Foraker R, Wassertheil-Smoller S, Stefanick ML, Kuller LH. Park NJ, et al. PLoS One. 2017 Sep 21;12(9):e0184174. doi: 10.1371/journal.pone.0184174. eCollection 2017. PLoS One. 2017. PMID: 28934233 Free PMC article. Clinical Trial.
Gernaat SAM, Ho PJ, Rijnberg N, Emaus MJ, Baak LM, Hartman M, Grobbee DE, Verkooijen HM. Gernaat SAM, et al. Breast Cancer Res Treat. 2017 Aug;164(3):537-555. doi: 10.1007/s10549-017-4282-9. Epub 2017 May 13. Breast Cancer Res Treat. 2017. PMID: 28503723 Free PMC article. Review.
Zullig LL, Shahsahebi M, Neely B, Hyslop T, Avecilla RAV, Griffin BM, Clayton-Stiglbauer K, Coles T, Owen L, Reeve BB, Shah K, Shelby RA, Sutton L, Dinan MA, Zafar SY, Shah NP, Dent S, Oeffinger KC. Zullig LL, et al. BMC Fam Pract. 2021 Nov 18;22(1):234. doi: 10.1186/s12875-021-01569-8. BMC Fam Pract. 2021. PMID: 34794388 Free PMC article. Clinical Trial.
Mikesell L, O'Malley DM, Kurtzman RT, Howard J, Bates B, Hemler JR, Fadem SJ, Ferrante JM, Bator A, Hudson SV, Crabtree BF. Mikesell L, et al. Cancer Med. 2024 May;13(9):e7219. doi: 10.1002/cam4.7219. Cancer Med. 2024. PMID: 38686635 Free PMC article.
Prior L, Featherstone H, O'Reilly D, Nugent K, Lim M, McCaffrey J, Higgins MJ, Kelly CM. Prior L, et al. Cardiooncology. 2021 Feb 23;7(1):8. doi: 10.1186/s40959-021-00096-w. Cardiooncology. 2021. PMID: 33622415 Free PMC article.
Zullig LL, Sung AD, Khouri MG, Jazowski S, Shah NP, Sitlinger A, Blalock DV, Whitney C, Kikuchi R, Bosworth HB, Crowley MJ, Goldstein KM, Klem I, Oeffinger KC, Dent S. Zullig LL, et al. JACC CardioOncol. 2022 Jun 21;4(2):149-165. doi: 10.1016/j.jaccao.2022.03.005. eCollection 2022 Jun. JACC CardioOncol. 2022. PMID: 35818559 Free PMC article. Review.
Finke D, Heckmann MB, Frey N, Lehmann LH. Finke D, et al. Front Physiol. 2021 Nov 26;12:729713. doi: 10.3389/fphys.2021.729713. eCollection 2021. Front Physiol. 2021. PMID: 34899373 Free PMC article. Review.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3